Axial Biotherapeutics
Founded
2016
2016
Geography
United States of America based
United States of America based
Funding
$44.500 M
$44.500 M
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders
Technologies
Microbiome StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet